The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Specific and sensitive detection of BRAF and KRAS mutations in clinical samples.
Vanessa Kelchner
No relevant relationships to disclose
Sergey Chupreta
No relevant relationships to disclose
Anjali Mishra
No relevant relationships to disclose
Ron Beaubien
No relevant relationships to disclose
Laurie Kurihara
No relevant relationships to disclose
Julie Laliberte
No relevant relationships to disclose
Andrey Mikheykin
No relevant relationships to disclose
David G. Beer
No relevant relationships to disclose
Vladimir Makarov
No relevant relationships to disclose